Login
$CMPX
$0.69 +$0.03 (4.07%) After hours

Company Executives

Officer Age In this role Joined 2025 pay Source
Thomas J. Schuetz Also a director
CHIEF EXECUTIVE OFFICER
Title from the Form 4 dated Feb 8, 2026
65 Not stated Not stated $5,097,150
Barry Shin
Chief Financial Officer
54 Since 2024
2 years
2024 $1,394,500
Jonathan E. Anderman
Senior Vice President, General Counsel & Corporate Secretary
43 Not stated Not stated Not reported
Neil Lerner
Chief Accounting Officer
58 Since 2025
1 year
2020 Not reported
Arjun Prasad
Chief Commercial Officer
48 Not stated 2026 Not reported
Cynthia Sirard
Chief Medical Officer
56 Not stated 2026 Not reported
Bing Gong
Chief Scientific Officer
50 Not stated 2015 Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
7
serving now
Average tenure
6.9 years
from year joined
Director Age On board Other public boards 2025 pay Source
Thomas J. Schuetz
65 2015
11 years
None stated Paid as CEO
Richard S. Lindahl
62 2023
3 years
None stated $163,400
Ellen Chiniara
67 2022
4 years
None stated $168,400
Mary Ann Gray
73 2022
4 years
BioAtla, Inc., Keros Therapeutics, Inc. $153,400
Philip J. Ferneau
64 2015
11 years
None stated $163,400
James P. Boylan
59 2022
4 years
Immunome, Inc., Zenas BioPharma, Inc. $158,400
Carl L. Gordon
61 2015
11 years
Keros Therapeutics Inc., Lomond Therapeutics Holdings, Inc. $173,400

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support